WESTON, Fla, April 20, 2004 (PRIMEZONE) -- Wall Street News Alert's "stocks to watch" this morning are: Swiss Medica (OTCBB:SWME), ComCam, Incorporated (OTCBB:CMCA), EFJ Inc. (Nasdaq:EFJI) and P-Com, Inc. (OTCBB:PCOM).
Aggressive investors need to watch Swiss Medica (OTCBB:SWME) this morning! Yesterday after the markets closed, the company issued a press release announcing that The Katz Group of Pharmacy retailers has agreed to sell O24 Pain Relief through their 1,600 retail locations across Canada!
This could be huge news for investors! "We are pleased that The Katz Group has signed on to be our first major pharmacy retail group," said Grant Johnson, President and COO of Swiss Medica. According to the press release, their 1,600 Canadian pharmacy retail locations will allow O24 to reach Canadians from coast to coast. "This giant retail partner takes O24 Pain Relief and Swiss Medica to a new level," continued Johnson.
"Having a company such as the Katz Group partner with Swiss Medica by listing O24 in their chain of stores gives the respectability that will make other large retailers notice, and not want to miss out on the great opportunity that Swiss Medica has to offer them," said Michael Bain, Vice President, Sales and Marketing for Swiss Medica.
Keep your eyes on this stock! The Katz Group is one of North America's leading drugstore operators with system sales of $4 billion. The company operates over 1,700 drugstores in Canada and the United States with over 15,000 employees. The Katz Group has retail operations, which include chains such as Pharma Plus Drug Marts Ltd., Pharmx Rexall Drug Stores Ltd., and Herbie's for Drug and Food Store, chains. The Katz Group, owns and operates Meditrust Healthcare Inc., Canada's only national mail order pharmacy business. Swiss Medica will be distributing O24 Pain Relief to The Katz Group via McKesson Corp. (NYSE:MCK), one of the largest distributors to North American pharmacies.
The stock closed at forty-one cents a share yesterday.
In case you are not familiar with the company: Swiss Medica commercializes proprietary bioscience products that relieve chronic ailments. They increase their market share through focused distribution strategies in multiple sales channels. Swiss Medica's mission is to be a world leader in the commercialization of life enhancing bioscience products that improve quality of lives.
Stocks showing interesting activity yesterday were: ComCam, Inc. (OTCBB:CMCA) up 89.8% on 3.9 million shares traded, EFJ Inc. (Nasdaq:EFJI) up 25.2% on 2.3 million shares traded and P-Com, Inc. (OTCBB:PCOM) up 13.2% on 10.2 million shares traded.
Commentary:
"Today will see economic reports on the index of leading economic indicators, and Friday a report on durable goods. Each will take the pulse of the various factors of the economy and will be closely scrutinized by economists," stated Sonja Rudd in Wall Street News Alert's daily commentary continued at: http://www.WallStreetNewsAlert.com.
WSNA's email alert service is free to those investors who sign up on the WSNA home page. The alert service is designed to notify investors of undervalued and often overlooked stocks. Subscribers are introduced to Special Situation companies that have the potential of showing increased activity. The Wall Street News Alert home page has experienced over 17 million hits. To subscribe to this free service, visit the Wall Street News Alert home page at http://www.wallstreetnewsalert.com and select the "join now" button.
Wall Street News Alert is a division of Wall Street Capital Funding LLC (WSCF). WSCF is not a registered broker/dealer and may not sell, offer to sell or offer to buy any security. WSCF profiles are not a solicitation or recommendation to buy, sell or hold securities. An offer to buy or sell can be made only with accompanying disclosure documents from the company offering or selling securities and only in the states and provinces for which they are approved. The material in this release is intended to be strictly informational. The companies that are discussed in this release have not approved the statements made in this release nor approved the timing of this release. All statements and expressions are the sole opinion of WSCF and are subject to change without notice. Information in this release is derived from a variety of sources including that company's publicly disseminated information, third parties and WSCF research. The accuracy or completeness of the information is not warranted and is only as reliable as the sources from which it was obtained. WSCF disclaims any and all liability as to the completeness or accuracy of the information contained and any omissions of material fact in this release. The release may contain technical inaccuracies or typographical errors. It is strongly recommended that any purchase or sale decision be discussed with a financial adviser, or a broker-dealer, or a member of any financial regulatory bodies. Investment in the securities of the companies' discussed in this release is highly speculative and carries a high degree of risk. WSCF is not liable for any investment decisions by its readers or subscribers. Investors are cautioned that they may lose all or a portion of their investment if they make a purchase in WSCF profiled stocks.
This profile is not without bias, and is a paid release. WSCF has been compensated for dissemination of company information on behalf of one or more of the companies mentioned in this release. WSCF has been compensated fifty-six thousand dollars for coverage of Swiss Medica (OTCBB:SWME), by the company, for services provided including dissemination of company information in this release. WSCF holds no shares of the stock. WSCF may receive shares for extension of its services. Any shares will be disclosed at such time that WSCF is aware of a clients desire to extend the original services. WSCF may have received shares of a company profiled in this release prior to the dissemination of the information in this release. WSCF may immediately sell some or any shares in a profiled company held by WSCF and may have previously sold shares in a profiled company held by WSCF. WSCF's services for a company may cause the company's stock price to increase, in which event WSCF would make a profit when it sells its stock in a company. In addition, WSCF's selling of a company's stock may have a negative effect on the market price of the stock. Market commentary provided by Sonja Rudd.
This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may," "future," "plan" or "planned," "will" or "should," "expected," "anticipates," "draft," "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a companies' annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and WSCF undertakes no obligation to update such statements.